Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Usual bubblish-ush mornings looking like hangovers lately
Yeah that block is now $132K so it's a battle now @ .60-.61
CVM needs to put out some news and it will clear $1 easily imo
CVM pullback but 126 block bid @.60 stop gap for bounce ?
GERN going
TRXI huge news just out: 5yr Contract w/State of W.Virginia:
The State of West Virginia Signs Five-Year Deal With TRX for Integrated Booking and Expense Management Services
TRXI
$0.81
-0.06 -6.9%
Released : Tuesday, August 25, 2009 3:30 PM
stock was $1.5/sh last week
BCON .73+ .05 on radar, GSCO (GS) bid support
JAZZ 7.33 on hi vol fr yesterday re: JAZZ 6.75 razzmatazz spiking
posted by: listener Date: Monday, August 24, 2009 12:55:54 PM
In reply to: None Post # of 220143 [Send a link via email]
JAZZ 6.75 razzmatazz spiking,.. easy $$ today for many sectors, where is the pull back many are expecting ?
Well apparently JPM was pumping 'risky subprime' today:
and i think this is what got financials rolling before Bove took the wind out of the sails.
But the whole game is pretty orchestrated imo.
JPM statement is like an alcoholic in the middle of an AAA meeting claiming to discover that taking more alcohol is really the cure to his illness
JPMorgan moves to 'overweight' risky subprime RMBS
Mon Aug 24, 2009 2:58pm EDT
http://www.reuters.com/article/marketsNews/idUSN2414587620090824
Biotechs buck; financials suck 'Buy the rumor' on biotechs; not at sell the news... yet
There won't be a big crash imo:markets will just freeze one of these days. They will get halted, like they did in '87 & 2001.
That is the spooky thought that comes to my mind. There is far too much euphoria over an overtly artificial prop job on the financial markets.
'hoping we can sequestor funds (ie run for the door before others get there) is another fallacy.
We are all in this together; sink or swim
No fortune teller here; I'm just a listener... continue to put my ears to the track
for now, the game continues...
glta
"FDIC-may be forced to seek ..assistance of foreign banks and private-equity funds to "
Since when does the FDIC turn to foreign banks & PEFs instead of the Treasury ????
http://www.nasdaq.com/aspx/stock-market-news-story.aspx?storyid=200908241130dowjonesdjonline000198&title=analyst-bovebig-fdic-assessment-comingbank-shares-too-high
BCRX, NVAX rocketed, might be Flu related. Added 5 vaccine related stocks:
BCRX, NVAX, VICL, INO, PURE, all performing well on above avg vol
Icon: Might be just a hiccup but otherwise this could be ominous to see Au & Ag drop so precipitously; crude is stable so i suspect it's not due to any unreported threat but rather a financial conundrum. Perhaps my recently cited posts from CNBC is indicating that markets are non too pleased by the "resecuritization of real estate mortgage investment conduits."
http://www.cnbc.com/id/32535976
Sudden plunge in SLV & GLD !
12:58 FAZ flew up, hasn't stopped; financials dropping
This is why financials are up:Deja Vu: Wall Street Repackages Debt for Sale
http://www.cnbc.com/id/32535976
the same ole shenanigans squared. 'just in case anyone forgot that Wall Street is still a big scam
JAZZ 6.75 razzmatazz spiking,.. easy $$ today for many sectors, where is the pull back many are expecting ?
GAPPER = ARIA
DJ US Appeals Crt To Reconsider Ariad-Eli Lilly Patent Dispute
SRS moving up, watch FAZ, TBT nhod on USD falling
IDOI & MCET have more moneflow than all other OTCs
IDOI & MCET for eod runs By far most moneyflow:
Look at InvestorsHub homepage & view transaction volume ($$$ traded) for OTC stocks & you'll see what i mean
http://investorshub.advfn.com/
IDOI & MCET for eod runs By far most moneyflow:
Look at InvestorsHub homepage & view transaction volume ($$$ traded) for OTC stocks & you'll see what i mean
http://investorshub.advfn.com/
AHR .74 sympathy to MPG? ramping w/big blocks
MCET taking off higher now .04 going to break yesterdays high
IDOI basing now look for the bounce
MCET .033+45% vol leader still play of the day
ADLR BIG NEWS AH $1.8/sh has $2.34/sh cash no debt!
$2.34/sh cash per yahoo statistics page:
http://finance.yahoo.com/q/ks?s=ADLR
Excerpt:
Pharmacoeconomic Analysis of Reported Use of ENTEREG(R) (alvimopan) Published in American Journal of Health-System Pharmacy
GSK
$39.37
+0.36 +0.9%
ADLR
$1.57
-0.04 -2.5%
Released : Thursday, August 20, 2009 4:37 PM
GSK
$39.37
+0.36 +0.9%
ADLR
$1.57
-0.04 -2.5%
Released : Thursday, August 20, 2009 4:37 PM
EXTON, PA and PHILADELPHIA, PA -- (MARKET WIRE) -- 08/20/09 -- Adolor Corporation (NASDAQ: ADLR) and GlaxoSmithKline (NYSE: GSK) today announced that an economic analysis of Phase 3 clinical trial data reported that the use of ENTEREG after bowel resection surgery decreased the amount of time patients spent in the hospital by one day, resulting in lower estimated hospital costs compared with placebo. The results, published in the American Journal of Health-System Pharmacy, were based on a post-hoc pharmacoeconomic analysis of pooled data consisting of 1,409 patients who participated in four randomized, double-blind, placebo-controlled, Phase 3 efficacy studies of ENTEREG conducted in North America.
ENTEREG is the first and only FDA-approved therapy indicated to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis, or reconnection of the intestine.
"The results from this analysis are positive for both bowel resection patients and healthcare providers," said Anthony J. Senagore, M.D., Vice President, Research and Education, Spectrum Health, Grand Rapids, MI, and one of the study authors. "The analysis of these Phase 3 North American studies concluded that using ENTEREG contributed to earlier discharge after surgery and, importantly, reduced overall estimated hospital costs."
ADLR BIG NEWS AH $1.8/sh has $2.34/sh cash no debt!
$2.34/sh cash per yahoo statistics page:
http://finance.yahoo.com/q/ks?s=ADLR
Excerpt:
Pharmacoeconomic Analysis of Reported Use of ENTEREG(R) (alvimopan) Published in American Journal of Health-System Pharmacy
GSK
$39.37
+0.36 +0.9%
ADLR
$1.57
-0.04 -2.5%
Released : Thursday, August 20, 2009 4:37 PM
GSK
$39.37
+0.36 +0.9%
ADLR
$1.57
-0.04 -2.5%
Released : Thursday, August 20, 2009 4:37 PM
EXTON, PA and PHILADELPHIA, PA -- (MARKET WIRE) -- 08/20/09 -- Adolor Corporation (NASDAQ: ADLR) and GlaxoSmithKline (NYSE: GSK) today announced that an economic analysis of Phase 3 clinical trial data reported that the use of ENTEREG after bowel resection surgery decreased the amount of time patients spent in the hospital by one day, resulting in lower estimated hospital costs compared with placebo. The results, published in the American Journal of Health-System Pharmacy, were based on a post-hoc pharmacoeconomic analysis of pooled data consisting of 1,409 patients who participated in four randomized, double-blind, placebo-controlled, Phase 3 efficacy studies of ENTEREG conducted in North America.
ENTEREG is the first and only FDA-approved therapy indicated to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis, or reconnection of the intestine.
"The results from this analysis are positive for both bowel resection patients and healthcare providers," said Anthony J. Senagore, M.D., Vice President, Research and Education, Spectrum Health, Grand Rapids, MI, and one of the study authors. "The analysis of these Phase 3 North American studies concluded that using ENTEREG contributed to earlier discharge after surgery and, importantly, reduced overall estimated hospital costs."
ADLR gapper big play tomorrow on AH news w/GSK
Pharmacoeconomic Analysis of Reported Use of ENTEREG(R) (alvimopan) Published in American Journal of Health-System Pharmacy
GSK
$39.37
+0.36 +0.9%
ADLR
$1.57
-0.04 -2.5%
Released : Thursday, August 20, 2009 4:37 PM
FAZ 25.68 got a bit spikey just now
TSFG 1.9/sh heavy vol;trading below tangible BV
RTK had nice bounce now HLCS getting block bids
FRE & FNM It's the Freddy & Fannie Show on right now
Hopefully the Kudlow interview gives it a boost.
right now traders are scalping/shorting it below the close.
I've seen this action before reverse rapidly, but surprised it hasn't moved up in anticipation yet.
RTK getting some coverage tonight on Kudlow Report:
http://www.cnbc.com/id/15838446
Guest:
Hunt Ramsbottom
Rentech CEO
LVLT value play? moving up finally at 1.18 found this on yhoo board:
(OT) This booming new telecom will benefit from stimulus funding, LVLT 18-Aug-09 01:33 pm
70 million homes/businesses need this service, LVLT. Omnicity Corp (OMCY) is the largest fixed Wireless Internet Service Provider (WISP) in the Midwest. The company has completed five major acquisitions in as many months. The stock is on track to be an attractive acquisition target, and has traded as high as $1.00 as recently as May. Omnicity continues to aggressively move forward with its plan to become a premier consolidator in the WISP industry, with the goal of "bringing broadband to the heartland." With an estimated 70m homes and small businesses in rural areas, this is a huge underserved market. Omnicity has tripled in size this past year, and the company is poised to tap into the $7 billion of government "Stimulus Package" funds marked for the development of broadband connectivity in rural communities. This could be a great ground floor opportunity.
RINO charging ahead leaving 12.55 hod in the dust
Biggie blocks buying HURN again 35 min slow turn upwards sharpening
Good pt. FAZ low of 27.12 looks like base
SYNM spiked to 2.92 fr 2.66 prolly sympathy to RTK